1,4:3,6-Dianhydrosorbitol 2-mono-nitrate and 5-mononitrate esters, a process for the preparation thereof and pharmaceutical compositions therefrom
申请人:CHIESI FARMACEUTICI S.p.A.
公开号:EP0290885A2
公开(公告)日:1988-11-17
Isosorbide 2- and 5-mononitrate esters with aliphatic, aryl, or cynnamic acids or diacids, or with alkylcarbonyloxy substituents optionally containing an isosorbide 2- or 5-mononitrate group, are useful in human therapy.
含有脂肪族、芳基或阴离子酸或二酸,或含有烷基羰氧基取代基(可选择含有 2-或 5-单硝酸异山梨酯基团)的 2-和 5-单硝酸异山梨酯可用于人体治疗。